GGrantIndex
Sort

51,593 grants matching hepatitis

NDA-Enabling Phase I Lofexidine Program

$468,517
James Alvan Longstreth · Us Worldmeds, Llc · U01 · FY2012 · DA

Modulating ROS by Electromagnetic Fields to Treat Type 2 Diabetes

$468,507
Val C Sheffield · University Of Iowa · R01 · FY2023 · DK

Modulating ROS by Electromagnetic Fields to Treat Type 2 Diabetes

$468,501
Val C Sheffield · University Of Iowa · R01 · FY2022 · DK

Modulating ROS by Electromagnetic Fields to Treat Type 2 Diabetes

$468,501
Val C Sheffield · University Of Iowa · R01 · FY2021 · DK

Using CAI to Enhance Drug Tx Staff HCV Knowledge and Communication Skills

$468,485
Hilary James Liberty · Social Sciences Innovations Corporation · R44 · FY2011 · DA

Role of ABCG5 and ABCG8 in Sterol Metabolism

$468,454
Helen H. Hobbs · Ut Southwestern Medical Center · R37 · FY2017 · HL

Role of ABCG5 and ABCG8 in Sterol Metabolism

$468,454
Helen H. Hobbs · Ut Southwestern Medical Center · R37 · FY2016 · HL

HIV HCV COINFECTION--ANTIVIRAL THERAPY AND FIBROSIS

$468,440
Johns Hopkins University · R01 · FY2001 · DA

Metabolic heterogeneity underlying hypertriglyceridemia in insulin resistance

$468,372
Daniel Vatner · Yale University · R01 · FY2022 · DK

Metabolic heterogeneity underlying hypertriglyceridemia in insulin resistance

$468,372
Daniel Vatner · Yale University · R01 · FY2023 · DK

Improved ultrasound imaging using elevated acoustic output

$468,326
Kathryn R Nightingale · Duke University · R01 · FY2016 · EB

Project 3 - Zuniga

$468,247
Elina I Zuniga · University Of California, San Diego · P01 · FY2018 · AI

Partnership for developing broad-spectrum microbicides

$468,242
Thomas Michael Zydowsky · Population Council · U01 · FY2008 · AI

TRIM mediated host antiviral responses during influenza virus infections

$468,231
Adolfo Garcia-Sastre · University Of Southern California · U19 · FY2012 · AI

Investigating the Immunosuppressive Function of lncRNA CRNDE in Hepatic Tumorigenesis

$468,139
Jinqiang Zhang · Tulane University Of Louisiana · R01 · FY2025 · CA

THE ATHEROPROTECTIVE EFFECTS OF SR-BI

$468,138
Massachusetts Institute Of Technology · R01 · FY2003 · HL

Diagnostics for Sepsis and Community-Acquired Pneumonia

$468,070
William G Weisburg · Nanogen, Inc. · U01 · FY2007 · AI

Young Adults and Drug Use: Careers and Familiar Factors

$468,041
Emory University · R01 · FY2002 · DA

Interactions of Endotoxin with Plasma and Cells

$468,011
Alan Wayne Varley · Ut Southwestern Medical Center · R01 · FY2010 · AI

Continuity of Care for Drug-Addicted Offenders in RI

$467,942
Rhode Island Hospital (Providence, Ri) · U01 · FY2002 · DA

National HIV Behavioral Surveillance System

$467,916
Alan Neaigus · New York City Health/Mental Hygiene · U1B · FY2012 · PS

The Effect of TCF7L2 on Glucose Metabolism

$467,813
Adrian Vella · Mayo Clinic Rochester · R01 · FY2012 · DK

Integration of Feeding and Glucose Metabolism by the Circadian Gene Network

$467,690
Joseph T Bass · Northwestern University At Chicago · R01 · FY2014 · DK

Integration of Feeding and Glucose Metabolism by the Circadian Gene Network

$467,690
Joseph T Bass · Northwestern University At Chicago · R01 · FY2012 · DK

Positive Immune-regulators During Chronic Viral Infections

$467,657
Elina I Zuniga · University Of California, San Diego · R01 · FY2015 · AI